CJC-1295 (With DAC)

Description

Description: * CJC-1295 with DAC is a modified GHRH analog developed to provide extended-release kinetics and prolonged growth hormone stimulation within long-term testing models.

• • The incorporation of the Drug Affinity Complex (DAC) bonds with serum albumin, drastically extending the peptide’s half-life and providing continuous stimulation to pituitary receptors.

  • This sustained action leads to a steady, elevated baseline of both Growth Hormone and Insulin-like Growth Factor 1 (IGF-1), accelerating lean tissue synthesis and adipose lipolysis.

  • Preclinical research focuses on its significant anti-aging implications, tissue structural regeneration, and systemic metabolic enhancement.

  • Designed exclusively for researchers investigating prolonged growth hormone modulation strategies and stable, long-acting biochemical platforms.